ArticleNature cancer2021

Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune evasion mechanisms.

Janne Lehtiö et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.